نتایج جستجو برای: jak2 mutation

تعداد نتایج: 294733  

Journal: :international journal of hematology-oncology and stem cell research 0
mehrdad payandeh medical biology research center, kermanshah university of medical sciences, kermanshah, iran. farhad shaveisi zadeh department of medical genetics, faculty of medicine, shahid beheshti university of medical sciences and health services, tehran mohammad erfan zare medical biology research center, kermanshah university of medical sciences, kermanshah, iran; studen kamran mansouri medical biology research center, kermanshah university of medical sciences, kermanshah, iran; depart reza khodarahmi medical biology research center, kermanshah university of medical sciences, kermanshah, iran; depart saeed alimoradi paramedical faculty, kermanshah university of medical sciences, kermanshah, iran

introduction: the myeloproliferative neoplasms (mpns) are a heterogeneous group of diseases characterized by excessive production of blood cells by  hematopoietic precursors. typically, they include polycythemia vera (pv), essential thrombocythemia (et), idiopathic myelofibrosis(imf), and chronic myeloid leukemia (cml). philadelphia chromosome is the final diagnostic test for cml. recently, jak...

ژورنال: پیاورد سلامت 2008
توگه, غلام رضا, علی مقدم, کامران, عین اللهی, ناهید, غفاری, سید حمیداله, فردوسی, شیرین, قوام زاده, اردشیر, موسوی, سید اسد اله, نادعلی, فاطمه, چاردولی, بهرام,

Background and Aim : Myeloproliferative neoplasms are clonal and heterogeneous disorders of hematopoietic stem cells lead to increase of one or more cell lines in the blood. Recently, the acquired mutation JAK2 V617F has been described in the majority of patients with myeloproliferative neoplasms (MPNs).This mutation is characterized by a G to T transverse at nucleotide 1849 in exon 12 of the J...

بهار, بابک, توگه, غلام‌رضا, درگاهی, حسین, علی‌مقدم, کامران, عین‌الهی, ناهید, غفاری, سیدحمید‌اله, قوام‌زاده, اردشیر, موسوی, اسداله, نادعلی, فاطمه, چهاردولی, بهرام, کریم‌زاده, پریسا, ‌فردوسی, شیرین,

Background: JAK2 is a nonreceptor tyrosine kinase that plays a major role in myeloid disorders. This mutation is characterized by a G to T transverse at nucleotide 1849 in exon 12 of the JAK2 gene, located on the chromosome 9p, leading to a substitution of valine to phenylalanine at amino acid position 617 in the JAK2 protein. In this study we compared the amplification refractory mutation (ARM...

Background and Objective: Janus kinase 2 (JAK2) and Myeloproliferative Leukemia (MPL) mutations are confirmatory indicators for Myeloproliferative Neoplasm (MPN). The current study was performed to determine the frequency of MPL mutation in MPN patients without JAK2 mutation, in order to assign MPL mutation frequency in North-East of Iran.Methods: Total o...

Journal: :international journal of hematology-oncology and stem cell research 0
parisa karimzadeh school of allied health sciences, tehran university of medical sciences seyed hamidollah ghaffari hematology-oncology and stem cell research center, shariati hospital, tehran university of medical sciences shirin ferdowsi school of allied health sciences, tehran university of medical sciences bahram chahardouli hematology-oncology and stem cell research center, shariati hospital, tehran university of medical sciences zohreh saltanatpouri hematology-oncology research center, emam khomeini hospital, tehran university of medical sciences nahid einollahi school of allied health sciences, tehran university of medical sciences

background and objectives: jak2 is a nonreceptor tyrosine kinase that plays a major role in myeloid disorders. jak2v617f mutation is characterized by a g to t transverse at nucleotide 1849 in exon 12 of the jak2 gene, located on the chromosome 9p, leading to a substitution of valine to phenylalanine at amino acid position 617 in the jak2 protein. in this study we compared two molecular methods ...

Gedik, Habip, Yokus, Osman,

Background: We aimed to investigate the etiologic causes and the existence of Janus kinase 2  mutation (JAK2) in cases with thrombocytosis. Methods: In this retrospective study, patients, who were admitted to hematology clinic with thrombocytosis between 2013 and 2015, were investigated in terms of the etiological causes of thrombocytosis and the existence of JAK2 mutation. Results: We retrospe...

A Ghavamzadeh, A Zaghal, B Bahar, B Chahardouli, H Dargahi, K Alimoghaddam, N Einollahi, P Karimzadeh, SA Mousavi, SH Ghaffari,

Abstract Objective JAK2 is a non-receptor tyrosine kinase that plays a major role in myeloid disorders. JAK2V617F mutation is characterized by a G to T transverse at nucleotide 1849 in exon 12 of the JAK2 gene, located on the chromosome 9p, leading to a substitution of valine to phenylalanine at amino acid position 617 in the JAK2 protein. Methods In this study we evaluated RNA from 89 pati...

Hossein Ayatollahi, Mahdi Balali Mood, Mahshid Jalili, Mohammad Hadi Sadeghian, Mohammad Hosein Basharati, Mohammad Reza Keramati ,

Background: Sulfur mustard was the most widely applied chemical warfare agent by the Iraqi army in Iran–Iraq war (1983-1988). Considering the role of sulfur mustard toxicity in hematopoietic neoplasms and also new role of JAK2 mutation in these neoplasms, we assessed this mutation and delayed hematologic complications in veterans exposed to sulfur mustard. Methods: This case control st...

Journal: :international journal of hematology-oncology and stem cell research 0
fatemeh nadali pathology department, school of medicine, isfahan university of medical sciences, isfahan, iran sh ferdowsi school of allied health sciences, tehran university of medical sciences, tehran, iran p karimzadeh school of allied health sciences, tehran university of medical sciences, tehran, iran bahram chahardouli hematology-oncology and bmt research center, shariati hospital, tehran university of medical science, tehran, iran n einollahi school of allied health sciences, tehran university of medical sciences, tehran, iran sa mousavi hematology-oncology and bmt research center, shariati hospital, tehran university of medical science, tehran, iran

jak2 is a tyrosine kinase that plays an important role in the signaling pathways of many hematopoietic growth factor receptors. a single acquired point mutation – v617f – in jak2 occurs in the great majority of patients with polycythemia vera (pv) and approximately half of the patients with idiopathic myelofibrosis (imf) or essential thrombocythemia (et). in contrast, the jak2-v617f mutation is...

Journal: :iranian journal of toxicology 0
محمدرضا کرامتی mohammad reza keramati phd of hematopathology, cancer molecular pathology research center, mashhad university of medical sciences, mashhad, iran. محمدهادی صادقیان mohammad hadi sadeghian phd of hematopathology, cancer molecular pathology research center, mashhad university of medical sciences, mashhad, iran. حسین آیت اللهی hossein ayatollahi ghaem hospital, mashhad university of medical scincesphd of hematopathology, cancer molecular pathology research center, mashhad university of medical sciences, mashhad, iran. محمدحسین بشارتی mohammad hosein basharati md, mashhad university of medical sciences, mashhad, iran. مهشید جلیلی mahshid jalili bsc of laboratory sciences, mashhad university of medical sciences, mashhad, iran. مهدی بلالی مود mahdi balali mood department of toxicology, mashhad university of medical sciences, mashhad, iran.

background: sulfur mustard was the most widely applied chemical warfare agent by the iraqi army in iran–iraq war (1983-1988). considering the role of sulfur mustard toxicity in hematopoietic neoplasms and also new role of jak2 mutation in these neoplasms, we assessed this mutation and delayed hematologic complications in veterans exposed to sulfur mustard. methods: this case control study was p...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید